COMMUNIQUÉS West-GlobeNewswire

Opthea Reports Positive Three-Month Data from Phase 1b Dose Escalation Study for OPT-302 in Diabetic Macular Edema
26/10/2018
MELBOURNE, Australia, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a clinical-stage biopharmaceutical company developing innovative biologic therapies to treat retinal diseases, today announced positive [...]
Data from Clinical and Pre-Clinical Trials Evaluating Verona Pharma’s RPL554 in Cystic Fibrosis Presented at North American Cystic Fibrosis Conference
26/10/2018
Pre-clinical findings show RPL554 stimulates rare class III and IV CFTR mutants Phase 2a results demonstrate RPL554 has favorable pharmacokinetic and pharmacodynamic profile in cystic fibrosis patients LONDON, Oct. 26, [...]
Amarin Schedules Webcast Discussion of Primary REDUCE-IT™ Trial Results Following Presentation at 2018 Scientific Sessions of American Heart Association
26/10/2018
Webcast to Commence at 7:15 p.m. CT / 8:15 p.m. ET, Saturday, November 10, 2018 BEDMINSTER, N.J. and DUBLIN, Ireland, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company [...]
Nomination Committee appointed for the 2019 Annual General Meeting in PledPharma
26/10/2018
Stockholm, October 26, 2018 . The Chairman of PledPharma AB has established a Nomination Committee for the Annual General Meeting, which is planned to be held on May 7 2019. The Nomination Committee is composed of [...]
C-RAD AB – Interim report January-September 2018
26/10/2018
Press release 2018-10-26 C-RAD REPORTS ALL-TIME HIGH IN QUARTELY ORDER INTAKE THIRD QUARTER 2018 Order intake: 64.2 (55.5) MSEK, 16%. Revenues: 46.7 (33.2) MSEK, 41%. Operating profit: 0.4 (-1.4) MSEK. Net results after [...]
Rule 2.9 announcement
26/10/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 26 October 2018 [...]
C-RAD AB – Interim report January-September 2018
26/10/2018
Press release 2018-10-26 C-RAD REPORTS ALL-TIME HIGH IN QUARTELY ORDER INTAKE THIRD QUARTER 2018 Order intake: 64.2 (55.5) MSEK, 16%. Revenues: 46.7 (33.2) MSEK, 41%. Operating profit: 0.4 (-1.4) MSEK. Net results after [...]
DBV Technologies Announces Initiation of Part B of Phase III Study in Peanut-Allergic Toddlers
26/10/2018
Montrouge, France, October 26, 2018 DBV Technologies Announces Initiation of Part B of Phase III Study in Peanut-Allergic Toddlers Study is expected to enroll a total of approximately 400 toddlers ages one to three at [...]
DBV Technologies annonce l'initiation du second volet de la phase III de l'essai réalisé sur de jeunes enfants allergiques à l'arachide
26/10/2018
Montrouge, France, le 26 octobre (07h30 CEST), 2018 DBV Technologies annonce l'initiation du second volet de la phase III de l'essai réalisé sur de jeunes enfants allergiques à l'arachide Le second volet étend l'étude à [...]
Novartis receives approval for Cosentyx® label update in Europe to include dosing flexibility in psoriatic arthritis
26/10/2018
New Cosentyx ® (secukinumab) label to include dosing flexibility up to 300 mg, based on clinical response, and 24-week structural data with subcutaneous (sc) regimens[1] Cosentyx inhibits progression of joint damage in [...]
FibroGen Presents Results from Two Phase 3 Studies of Roxadustat for the Treatment of Anemia Associated with Chronic Kidney Disease Conducted in China at American Society of Nephrology Kidney Week 2018 Annual Meeting
26/10/2018
SAN FRANCISCO, Oct. 25, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), a leading biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics, and FibroGen China Medical [...]
Bionano Genomics to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018
26/10/2018
Call Scheduled for Wednesday, November 7 th @ 4:30pm Eastern Time SAN DIEGO, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets [...]
Adherium Announces Q1 Fiscal Year 2019 Investor Conference Call
26/10/2018
SAN MATEO, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, will host a conference call on Tuesday, October 30, 2018 at 6. [...]
TOMI Environmental Solutions, Inc. Exhibits SteraMist™ Disinfection Products at the American Association for Laboratory Animal Science (AALAS) Annual Meeting
25/10/2018
BEVERLY HILLS, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global provider of infection prevention and decontamination products, services and research, including [...]
MannKind Corporation to Hold 2018 Third Quarter Financial Results Conference Call on November 1, 2018
25/10/2018
WESTLAKE VILLAGE, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will host a conference call to discuss the 2018 third quarter and year-to-date financial results and other corporate [...]
Adaptimmune to Report Third Quarter 2018 Financial Results and Business Update on Tuesday, November 6, 2018
25/10/2018
PHILADELPHIA and OXFORD, United Kingdom, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, will announce financial results for the Third Quarter [...]
Spring Bank Pharmaceuticals Reports Third Quarter Financial Results
25/10/2018
HOPKINTON, Mass., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]
Histogenics Corporation to Report Third Quarter 2018 Financial Results on November 8, 2018
25/10/2018
WALTHAM, Mass., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function, announced [...]
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
25/10/2018
MENLO PARK, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report its third quarter 2018 financial results and provide a corporate update on November 1 [...]

Pages